EMBC 2-WEEK DEADLINE ALERT: Hagens Berman Investigates Alleged Securities Law Violations at Embecta Corp. (NASDAQ: EMBC) Following Pending Class Action Litigation

Hagens Berman announced an investigation into Embecta Corp. regarding alleged violations of federal securities laws, following a filed class action lawsuit in New Jersey. The complaint alleges Embecta misled investors about the stability of its insulin pen needle business, contradicting subsequent disclosures of significant revenue declines and a dividend cut. Investors who suffered losses between Nov.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.